Patrick A Murphy1, Richard O Hynes2. 1. From the Howard Hughes Medical Institute, David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA. 2. From the Howard Hughes Medical Institute, David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA. rohynes@mit.edu.
Abstract
OBJECTIVE: Abnormally low-flow conditions, sensed by the arterial endothelium, promote aneurysm rupture. Fibronectin (FN) is among the most abundant extracellular matrix proteins and is strongly upregulated in human aneurysms, suggesting a possible role in disease progression. Altered FN splicing can result in the inclusion of EIIIA and EIIIB exons, generally not expressed in adult tissues. We sought to explore the regulation of FN and its splicing and their possible roles in the vascular response to disturbed flow. APPROACH AND RESULTS: We induced low and reversing flow in mice by partial carotid ligation and assayed FN splicing in an endothelium-enriched intimal preparation. Inclusion of EIIIA and EIIIB was increased as early as 48 hours, with negligible increases in total FN expression. To test the function of EIIIA and EIIIB inclusion, we induced disturbed flow in EIIIAB(-/-) mice unable to include these exons and found that they developed focal lesions with hemorrhage and hypertrophy of the vessel wall. Acute deletion of floxed FN caused similar defects in response to disturbed flow, consistent with a requirement for the upregulation of the spliced isoforms, rather than a developmental defect. Recruited macrophages promote FN splicing because their depletion by clodronate liposomes blocked the increase in endothelial EIIIA and EIIIB inclusion in the carotid model. CONCLUSIONS: These results uncover a protective mechanism in the inflamed intima that develops under disturbed flow, by showing that splicing of FN mRNA in the endothelium, induced by macrophages, inhibits hemorrhage of the vessel wall.
OBJECTIVE: Abnormally low-flow conditions, sensed by the arterial endothelium, promote aneurysm rupture. Fibronectin (FN) is among the most abundant extracellular matrix proteins and is strongly upregulated in human aneurysms, suggesting a possible role in disease progression. Altered FN splicing can result in the inclusion of EIIIA and EIIIB exons, generally not expressed in adult tissues. We sought to explore the regulation of FN and its splicing and their possible roles in the vascular response to disturbed flow. APPROACH AND RESULTS: We induced low and reversing flow in mice by partial carotid ligation and assayed FN splicing in an endothelium-enriched intimal preparation. Inclusion of EIIIA and EIIIB was increased as early as 48 hours, with negligible increases in total FN expression. To test the function of EIIIA and EIIIB inclusion, we induced disturbed flow in EIIIAB(-/-) mice unable to include these exons and found that they developed focal lesions with hemorrhage and hypertrophy of the vessel wall. Acute deletion of floxed FN caused similar defects in response to disturbed flow, consistent with a requirement for the upregulation of the spliced isoforms, rather than a developmental defect. Recruited macrophages promote FN splicing because their depletion by clodronate liposomes blocked the increase in endothelial EIIIA and EIIIB inclusion in the carotid model. CONCLUSIONS: These results uncover a protective mechanism in the inflamed intima that develops under disturbed flow, by showing that splicing of FN mRNA in the endothelium, induced by macrophages, inhibits hemorrhage of the vessel wall.
Authors: D Dubin; J H Peters; L F Brown; B Logan; K C Kent; B Berse; S Berven; B Cercek; B G Sharifi; R E Pratt Journal: Arterioscler Thromb Vasc Biol Date: 1995-11 Impact factor: 8.311
Authors: Yasuhisa Kanematsu; Miyuki Kanematsu; Chie Kurihara; Yoshiteru Tada; Tsung-Ling Tsou; Nico van Rooijen; Michael T Lawton; William L Young; Elena I Liang; Yoshitsugu Nuki; Tomoki Hashimoto Journal: Stroke Date: 2010-11-24 Impact factor: 7.914
Authors: Renu Virmani; Frank D Kolodgie; Allen P Burke; Aloke V Finn; Herman K Gold; Thomas N Tulenko; Steven P Wrenn; Jagat Narula Journal: Arterioscler Thromb Vasc Biol Date: 2005-07-21 Impact factor: 8.311
Authors: Anil K Chauhan; Janka Kisucka; Maria R Cozzi; Meghan T Walsh; Federico A Moretti; Monica Battiston; Mario Mazzucato; Luigi De Marco; Francisco E Baralle; Denisa D Wagner; Andrés F Muro Journal: Arterioscler Thromb Vasc Biol Date: 2007-11-08 Impact factor: 8.311
Authors: Brian C Tieu; Chang Lee; Hong Sun; Wanda Lejeune; Adrian Recinos; Xiaoxi Ju; Heidi Spratt; Dong-Chuan Guo; Dianna Milewicz; Ronald G Tilton; Allan R Brasier Journal: J Clin Invest Date: 2009-11-16 Impact factor: 14.808
Authors: A Wayne Orr; John M Sanders; Melissa Bevard; Elizabeth Coleman; Ian J Sarembock; Martin Alexander Schwartz Journal: J Cell Biol Date: 2005-04-04 Impact factor: 10.539
Authors: Noor Jailkhani; Jessica R Ingram; Mohammad Rashidian; Steffen Rickelt; Chenxi Tian; Howard Mak; Zhigang Jiang; Hidde L Ploegh; Richard O Hynes Journal: Proc Natl Acad Sci U S A Date: 2019-05-08 Impact factor: 11.205
Authors: Christopher J Turner; Kwabena Badu-Nkansah; Denise Crowley; Arjan van der Flier; Richard O Hynes Journal: Development Date: 2015-02-15 Impact factor: 6.868
Authors: Zaki Al-Yafeai; Arif Yurdagul; Jonette M Peretik; Mabruka Alfaidi; Patrick A Murphy; A Wayne Orr Journal: Arterioscler Thromb Vasc Biol Date: 2018-11 Impact factor: 8.311
Authors: Yao Wei Lu; Anthony M Lowery; Li-Yan Sun; Harold A Singer; Guohao Dai; Alejandro P Adam; Peter A Vincent; John J Schwarz Journal: Arterioscler Thromb Vasc Biol Date: 2017-05-04 Impact factor: 8.311
Authors: Yao Wei Lu; Nina Martino; Brennan D Gerlach; John M Lamar; Peter A Vincent; Alejandro P Adam; John J Schwarz Journal: Arterioscler Thromb Vasc Biol Date: 2021-01-07 Impact factor: 8.311
Authors: Patrick A Murphy; Noor Jailkhani; Sarah-Anne Nicholas; Amanda M Del Rosario; Jeremy L Balsbaugh; Shahinoor Begum; Amy Kimble; Richard O Hynes Journal: Arterioscler Thromb Vasc Biol Date: 2020-11-19 Impact factor: 8.311